AMRIT Pharmacies Expansion — Advancing Public Healthcare Access in India
Introduction
On 15 November 2025, India marked the 10th anniversary of the AMRIT Pharmacy initiative—Affordable Medicines and Reliable Implants for Treatment. To commemorate the milestone, Union Health Minister J.P. Nadda launched 10 new AMRIT outlets across the country at Bharat Mandapam, New Delhi.
The initiative represents a key effort to reduce healthcare expenditure and ensure equitable access to essential medicines.
Background: AMRIT & Jan Aushadhi — India’s Affordable Medicines Ecosystem
Launched in 2015, AMRIT aims to provide:
- Life-saving medicines
- Critical implants
- Essential drugs
at 50%–90% discount.
Together with the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), AMRIT forms a two-tier support system for affordable medicines.
This is important because nearly 50% of India’s out-of-pocket expenditure (OOPE) is spent on medicines alone.
Key Announcements on the 10th Anniversary
1. Launch of 10 New AMRIT Outlets
- Expands access in underserved regions
- Supports decentralised public health delivery
2. Vision for Universal Access
The minister announced an ambitious goal:
- An AMRIT pharmacy in every district hospital
- An AMRIT outlet in every medical college
This aligns with the broader national mission of strengthening affordable healthcare infrastructure.
Significance for Public Health
1. Reducing Out-of-Pocket Expenditure
OOPE pushes millions into poverty every year. Discounted essential medicines provide immediate relief for:
- Chronic illnesses (diabetes, hypertension)
- Cancer treatment
- Cardiac care
- Orthopaedic implants
2. Preventing Treatment Abandonment
High medicine prices often lead to patients discontinuing long-term treatment. AMRIT prevents this by making therapy affordable.
3. Strengthening Public Health Security
Low-cost access to essential drugs helps:
- Improve adherence to treatment
- Reduce morbidity and mortality
- Lower dependence on private pharmacies
4. Convergence with Other Schemes
AMRIT complements existing public health programmes like:
- Ayushman Bharat & PM-JAY
- PMBJP
- Home-Based Newborn Care (HBNC)
Together, they create an integrated, inclusive healthcare ecosystem.
Challenges That Still Remain
Despite the success, several operational hurdles persist:
1. Supply Chain Gaps
Remote and hilly areas face difficulties in ensuring uninterrupted supply.
2. Low Public Awareness
Many citizens remain unaware of AMRIT and Jan Aushadhi benefits.
Improved Information, Education, and Communication (IEC) efforts are needed.
3. Quality Standardisation
Ensuring trust in generic medicines requires:
- Strong oversight by NPPA
- Consistent monitoring by CDSCO
4. Integration with Hospitals
Not all district hospitals have AMRIT outlets yet.
Better coordination with state health departments is necessary.
Conclusion
The expansion of AMRIT Pharmacies marks an important milestone in India’s journey towards equitable and affordable healthcare. Yet, the next phase must focus on:
- Strengthening supply chains
- Enhancing quality assurance
- Ensuring universal coverage
- Increasing public awareness
Only then can India move closer to achieving Universal Health Coverage (UHC) and ensure that no citizen is denied essential treatment due to financial constraints.